Radiosurgery for mesial temporal lobe epilepsy following ROSE trial guidelines — A planning comparison between Gamma Knife, Eclipse, and Brainlab. Issue 10 (18th September 2019)

• Record Type: Journal Article
• Authors: Narayanasamy, Ganesh; Morrill, Steven; Cousins, David; Liu, Joshua; Deshazer, Garron; Garner, Wesley; Galhardo, Edvaldo; Serletis, Demitre; Penagaricano, Jose
• Is Part Of: Journal of applied clinical medical physics. Volume 20:Issue 10(2019)
• Page Start: 134
• Page End: 141
• Publication Date: 2019-09-18
• Subjects: epilepsy -- epilepsy Gamma Knife -- epilepsy SRS -- ROSE trial -- temporal lobectomy; Medical physics -- Periodicals; Clinical medicine -- Periodicals; Health Physics; Clinical Medicine; Electronic journals; Periodicals; Periodicals; Fulltext; Internet Resources; 610.153
• DOI: 10.1002/acm2.12724
• Languages: English
• ISSNs: 1526-9914

Abstract

Abstract: Purpose: This study aims to compare stereotactic radiosurgery (SRS) planning of epilepsy that complies with Radiosurgery or Open Surgery for Epilepsy (ROSE) guidelines in GammaKnife, non‐coplanar conformal (NCC) plan in Eclipse, dynamic conformal arc (DCA) plan in Brainlab, and a volumetric modulated arc therapy (VMAT) plan in Eclipse. Methods: Twenty plans targeting Mesial temporal lobe epilepsy (MTLE) was generated using GammaKnife, Eclipse with 20 NCC beams, Brainlab with 5 DCA, and Eclipse VMAT with 4 arcs observing ROSE trial guidelines. Multivariate analysis of variance and Wilcoxon signed‐rank test were used to compare dosimetric data of the plans and perform pairwise comparison, respectively. Results: The plans obeyed the recommended prescription isodose volume (PIV) within 5.5–7.5 cc and maximum doses to brainstem, optic apparatus (OA) of 10 and 8 Gy, respectively, for a prescription dose of 24 Gy. The volumes of the target were in the range 4.0–7.4 cc. Mean PIV, maximum dose to brainstem, OA were 6.5 cc, 10 Gy, 7.9 Gy in GammaKnife; 7.2 cc, 6.1 Gy, 4.5 Gy in Eclipse NCC; 7.2 cc, 6.4 Gy, 5.7 Gy in Brainlab DCA; and 5.2 cc, 8.4 Gy, 6.1 Gy in Eclipse VMAT plans, respectively. Multivariate analysis of variance showed significant differences among the 4 SRS planning techniques ( P ‐values < 0.01). Conclusions: Among the 4 SRS planning methods, VMAT with least PIV and acceptable maximum doses to brainstem and OA showed highest compliance with ROSE trial. Having the most conformal dose distribution and least dose inhomogeneity, VMAT scored higher than GK, Eclipse NCC, and Brainlab DCA plans.